IL-6 blocks a discrete early step in lymphopoiesis

Area of Science:

• Hematology
• Immunology
• Molecular Biology

Background:

• Animals lacking Src homology 2 domain-containing inositol 5-phosphatase (SHIP) exhibit altered blood cell development.
• These alterations include reduced lymphopoiesis (lymphocyte production) and increased myelopoiesis (myeloid cell production).
• Elevated levels of interleukin-6 (IL-6) are implicated as a mediator of these effects.

Purpose of the Study:

• To investigate the mechanism by which SHIP deficiency impacts lymphopoiesis.
• To determine the role of IL-6 in suppressing lymphoid lineage commitment in SHIP-deficient animals.
• To identify the specific hematopoietic progenitor cells targeted by IL-6.

Main Methods:

• Analysis of SHIP-/- mice to observe lymphopoiesis and myelopoiesis.
• In vitro experiments using recombinant IL-6 on hematopoietic progenitors.
• Generation and analysis of SHIP-/- IL-6-/- double-deficient mice.

Main Results:

• SHIP deficiency leads to a block in lymphopoiesis by suppressing lymphoid lineage choice in uncommitted progenitors.
• Recombinant IL-6 reproduces this suppression in vitro, acting directly on hematopoietic progenitors.
• The lymphopoiesis block is partially rescued in SHIP-/- IL-6-/- double-deficient mice.
• IL-6 enhances proliferation of lymphoid-committed progenitors, indicating its target cells are earlier hematopoietic stem cells or multipotent progenitors.

Conclusions:

• SHIP deficiency impairs lymphopoiesis through IL-6-mediated suppression of early progenitor lymphoid lineage commitment.
• IL-6 directly targets hematopoietic stem cells or multipotent progenitors, hindering their differentiation into lymphoid cells.
• This mechanism provides insight into the lymphopenia observed in inflammatory conditions.